These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 45073)

  • 1. [Neurovegetative regulation of the heart and use of beta-adrenergic blocking agents].
    Gemelli A
    Arch Sci Med (Torino); 1979; 136(4):561-5. PubMed ID: 45073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autonomic receptor--effector coupling during post-natal development.
    Robinson RB
    Cardiovasc Res; 1996 Feb; 31 Spec No():E68-76. PubMed ID: 8681348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists.
    Packer M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S38-43. PubMed ID: 2478808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of cardiac insufficiency by beta-blockaders. A review of the literature and discussion].
    Hermida JS; Jarry G; Bertrand S; Guillaumont MP; Rey JL; Bernasconi P
    Ann Cardiol Angeiol (Paris); 1990 Feb; 39(2):103-7. PubMed ID: 1970467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenergic receptors and beta-blocking agents in coronary pathology].
    Chemin P; Rossi A
    Ann Cardiol Angeiol (Paris); 1974 Oct; 23(5):427-40. PubMed ID: 4155261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
    Lüderitz B
    Z Kardiol; 1986; 75 Suppl 5():41-6. PubMed ID: 2435070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS; Illsley SS
    Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of beta-adrenergic blocking drugs in hypertension.
    Prichard BN; Owens CW
    Clin Physiol Biochem; 1990; 8 Suppl 2():1-10. PubMed ID: 1982756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic blocking drugs in severe heart failure.
    Fowler M
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S20-6. PubMed ID: 12447158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-adrenergic blocking agents in congestive heart failure.
    Krukemyer JJ
    Clin Pharm; 1990 Nov; 9(11):853-63. PubMed ID: 1980240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta blockade and the effects of stress on the normal and ischaemic heart.
    Prichard BN
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S9-18. PubMed ID: 6118124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action and pharmacological classification of beta-adrenergic receptor blocking drugs.
    Singh BN
    Singapore Med J; 1973 Sep; 14(3):400-2. PubMed ID: 4149718
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic blocking agents in the treatment of patients after a myocardial infarction.
    Goldstein S
    Henry Ford Hosp Med J; 1991; 39(3-4):200-5. PubMed ID: 1687143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neural regulation of the heart from the clinical standpoint].
    Rothlin M
    Schweiz Rundsch Med Prax; 1971 Mar; 60(13):403-7. PubMed ID: 4397285
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic analysis of ventricular repolarization duration from 24-hour Holter recordings.
    Merri M; Alberti M; Moss AJ
    IEEE Trans Biomed Eng; 1993 Dec; 40(12):1219-25. PubMed ID: 7907317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of functional capacity and survival in congestive heart failure. Effects of activation of the sympathetic nervous system.
    Packer M
    Postgrad Med; 1988 Feb; Spec No():96-103. PubMed ID: 2894667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure.
    Gan RT; Li WM; Xiu CH; Shen JX; Wang X; Wu S; Kong YH
    Chin Med J (Engl); 2007 Dec; 120(24):2250-5. PubMed ID: 18167212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta3-adrenoceptor in the eel (Anguilla anguilla) heart: negative inotropy and NO-cGMP-dependent mechanism.
    Imbrogno S; Angelone T; Adamo C; Pulerà E; Tota B; Cerra MC
    J Exp Biol; 2006 Dec; 209(Pt 24):4966-73. PubMed ID: 17142685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.